CHARACTERISTICS AND TREATMENT OUTCOMES OF HOSPITAL-ACQUIRED PNEUMONIA CAUSED BY ACINETOBACTER BAUMANNII IN THE RESPIRATORY DEPARTMENT OF THONG NHAT HOSPITAL

Huỳnh Thị Thanh Ngân 1 , Ngô Thế Hoàng 1 , , Phạm Minh Trí 1 , Phạm Thị Thu Hồng 1
1 Thong Nhat Hospital image/svg+xml
* Corresponding author:

Article Information

A 50-Year Journey in Establishing a Position and Promoting Sustainable Development in Healthcare and Geriatrics
Metrics
Downloads: 105 Views: 125
DOI
10.63947/bvtn.v1i1.18
Published
2025-06-03
Issue Vol. 1 No. 1 (2025): A 50-Year Journey in Establishing a Position and Promoting Sustainable Development in Healthcare and Geriatrics
Section
Original Paper

Download Article

PDF (Vietnamese)
PDF

How to Cite

1.
Ngân HTT, Hoàng NT, Trí PM, Hồng PTT. CHARACTERISTICS AND TREATMENT OUTCOMES OF HOSPITAL-ACQUIRED PNEUMONIA CAUSED BY ACINETOBACTER BAUMANNII IN THE RESPIRATORY DEPARTMENT OF THONG NHAT HOSPITAL. JHA [Internet]. Vietnam; 2025 Jun. 3 [cited 2025 Aug. 13];1(1):115–121. https://tcsuckhoelaohoa.vn/bvtn/article/view/21 doi: 10.63947/bvtn.v1i1.18
Loading citation...
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

This study aimed to characterize the clinical and paraclinical features, treatment outcomes, and antibiotic resistance patterns of Acinetobacter baumannii-associated hospital-acquired pneumonia (HAP) in elderly patients. A cross-sectional descriptive study was carried out on 75 hospitalized patients aged 60 years and above who were diagnosed with A. baumannii-related HAP. The study took place at the Department of Respiratory Medicine, Thong Nhat Hospital, from April 2024 to April 2025. The majority of patients exhibited clinical manifestations including fever, productive cough, dyspnea, auscultatory crackles, leukocytosis, elevated C-reactive protein (CRP) levels, and chest radiographs revealing infiltrates in over 70% of cases. Altered mental status was notably prevalent among elderly patients, affecting 65.3%. The most frequently utilized empirical antibiotic regimens were ceftazidime plus gentamicin, piperacillin/tazobactam plus levofloxacin, and ceftazidime pus ciprofloxacin; however, only 21.3% of these empirical therapies aligned with antibiotic susceptibility testing results. Multidrug-resistant A. baumannii accounted for 84% of isolates, with 21.3% classified as multidrug-resistant (MDR), 50.7% as extensively drug-resistant (XDR), and 13.3% as pandrug-resistant (PDR). Resistance rates to β-lactam/β-lactamase inhibitor combinations and cephalosporins exceeded 85%, resistance to quinolones and aminoglycosides ranged between 60–70%, and carbapenem resistance was approximately 50%. Colistin was identified as the sole antibiotic demonstrating efficacy exceeding 70%. The treatment failure rate was 65.3%, which was significantly associated with age, duration of hospitalization, and inappropriate empirical antibiotic therapy. The clinical and paraclinical characteristics of hospital-acquired pneumonia (HAP) caused by A. baumannii in elderly patients are distinctive, with altered mental status being a prominent feature. A. baumannii exhibited resistance to the majority of antibiotics tested, leaving colistin as the only relatively effective therapeutic option. Nonetheless, managing HAP caused by A. baumannii in the elderly remains a formidable challenge, reflected in a notably high mortality rate. Factors such as advanced age, prolonged hospitalization, and inappropriate empirical antibiotic use were significantly correlated with treatment failure

Keywords

Hospital-acquired pneumonia multidrug resistance Acinetobacter baumannii elderly antibiotic resistance

References

  1. Hội Hồi sức cấp cứu và Chống độc Việt Nam, Hội Hô hấp Việt Nam. Khuyến cáo chẩn đoán và điều trị viêm phổi bệnh viện, viêm phổi thở máy. Hà Nội: Nhà xuất bản Y học; 2023.
  2. Vo TPM, Dinh TC, Phan HV, et al. Ventilator-associated pneumonia caused by multidrug-resistant gram-negative bacteria in Vietnam: resistance, outcomes, and colistin-associated adverse effects. Antibiotics. 2022;11(11):1765. DOI: https://doi.org/10.3390/healthcare10091765
  3. Diep DTH, Phung CT. Distribution of drug resistance genes and clinical characteristics of Acinetobacter baumannii at University Medical Center HCMC. Sci Technol Dev J. 2023;26(Suppl 1):17–24.
  4. Bostanghadiri N, Ghalavand Z, Hashemi A, et al. Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review. Antimicrob Resist Infect Control. 2024;13(1):24. DOI: https://doi.org/10.1186/s13756-024-01376-7
  5. Marino A, Augello E, Stracquadanio S, et al. Acinetobacter baumannii: resistance, treatments, and future innovations. Int J Mol Sci. 2024;25(13):6814. DOI: https://doi.org/10.3390/ijms25136814
  6. Phạm Hồng Thắm. Tình hình sử dụng kháng sinh trong điều trị viêm phổi do Acinetobacter baumannii. In: Hội nghị Hô hấp TP. Hồ Chí Minh; 2023.
  7. Dinh TC, Cao TTM. Challenges in treating MDR Acinetobacter baumannii infections in Vietnam. Trop Med Infect Dis. 2023;8(2):89.
  8. Mizokami F, Koide Y, Noro T, et al. Polypharmacy with common diseases in hospitalized elderly patients. Am J Geriatr Pharmacother. 2020;18(2):123–128. DOI: https://doi.org/10.1016/j.amjopharm.2012.02.003
  9. Tomys-Składowska J, Domańska OM, Kozłowska-Wojciechowska M, et al. Pneumonia in geriatric patients: etiology, clinical features, diagnosis, and prevention. Healthcare (Basel). 2023;11(6):829. DOI: https://doi.org/10.2478/jhsm-2023-0017
  10. Nguyễn Ngọc Trâm. Đề kháng carbapenem trong viêm phổi thở máy: thực trạng tại Bệnh viện Bạch Mai. Y học lâm sàng. 2022;32(3):145–151.
  11. Vũ Nhi Thái, Trần Huy Hoàng. Kháng sinh đồ của Acinetobacter baumannii tại các bệnh viện tuyến cuối Việt Nam. Tạp chí Khoa học Đại học Tân Trào. 2024.

License

© 2025 The Author(s). Published by Journal of Health and Aging.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.